Associated Papers
ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?
Bruckmueller H et al.
Expert Opinion on Drug Metabolism & Toxicology, 2021
Cystic fibrosis transmembrane conductance regulator mutations in azoospermic and oligospermic men and their partners.
Gallati S et al.
Reproductive Biomedicine Online, 2009
Development of a fingerprinting panel using medically relevant polymorphisms.
Cross DS et al.
Bmc Medical Genomics, 2009
19379518 (PubMed )
Supplement: 1755-8794-2-17-S2.doc
A haplotype framework for cystic fibrosis mutations in Iran.
Elahi E et al.
The Journal of Molecular Diagnostics : Jmd, 2006
MDR1 genotype-related pharmacokinetics and pharmacodynamics.
Sakaeda T et al.
Biological & Pharmaceutical Bulletin, 2002
Overview of the pharmacogenetics of HIV therapy.
Rodríguez-Nóvoa S et al.
The Pharmacogenomics Journal, 0
Select a paper to view details